Sandeep Agarwala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sandeep Agarwala has a total of 334 co-authors. Here are the top co-authors by number of shared publications:
Veereshwar Bhatnagar
Department of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi, India
21 shared publicationsSameer Bakhshi
Department of Medical Oncology, Institute of Medical Sciences, IRCH, New Delhi, India
13 shared publications- Devendra Kumar Yadav
Department of Paediatric Surgery, All India Institute of Medical Sciences, New Delhi, India
12 shared publications Vishesh Jain
Department of Paediatric Surgery, All India Institute of Medical Sciences, AIIMS, Ansari Nagar, New Delhi, India
12 shared publications- Vishesh Jain
Department of Paediatric Surgery, All India Institute of Medical Sciences, New Delhi, India
12 shared publications Anjan Dhua
Department of Pediatric Surgery, AIIMS, New Delhi, India
11 shared publications
Latest Publications
- 22 September 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1) , 417
Semi-automated erythema quantification in infantile haemangioma receiving propranolol: a pilot feasibility study
Background Infantile haemangioma (IH) is the most common vascular tumour of infancy. Propranolol is first-line treatment, but response monitoring relies on subjective clinical assessment. Semi-automated photographic erythema quantification may offer a reproducible, low-cost adjunct monitoring tool. Objectives To develop a semi-automated Python-based erythema quantification tool for serial clinical photographs of IH, evaluate its feasibility and intra-rater reliability, and characterise the relationship between colour-based erythema change and clinician-assessed composite response. Methods Retrospective analysis of a prospective photographic registry at a tertiary paediatric surgery centre. Forty-nine infants with IH treated with propranolol were included. Serial clinical photographs (n = 251) were analysed using a custom Python tool. The erythema index (EI = [R − G] / [R + G + B]), a formula validated for quantification of cutaneous erythema from digital photographs, was calculated from manually selected lesion regions of interest (ROI). Intra-rater reliability was assessed by re-rating 22 photographs from five patients one week apart. Absolute EI change was correlated with prospectively recorded, blinded clinician response scores (0–10). Results Of 251 photographs, 242 (96.4%) were analysable (mean 4.9 visits per patient, range 2–11). Intra-rater reliability was high: ICC(A,1) = 0.990(95% CI 0.97–1.00); Bland–Altman mean difference − 0.005 EI units (95% limits of agreement − 0.023 to + 0.013). Mean baseline EI was 0.122 ± 0.058 and mean final EI was 0.115 ± 0.053. Absolute EI change did not correlate with clinician response scores (Pearson r = − 0.084, 95% CI − 0.357 to 0.202, p = 0.566; Spearman r = − 0.087, p = 0.554), consistent across three sensitivity analyses. Conclusions Semi-automated erythema quantification from clinical photographs of IH is feasible with high intra-rater reliability. These pilot findings should be interpreted as hypothesis-generating; the study is underpowered for definitive correlation testing, and prospective replication in an adequately powered cohort is required. In this pilot cohort, colour-based EI change alone was insufficient to track the clinician’s composite response assessment under real-world uncalibrated photography conditions, consistent with the partial-biomarker nature of colour-only analysis. Prospective studies with standardised photography incorporating colorimetric calibration and composite colour-plus-area scoring are warranted.
- 22 September 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1) , 417
Semi-automated erythema quantification in infantile haemangioma receiving propranolol: a pilot feasibility study
Background Infantile haemangioma (IH) is the most common vascular tumour of infancy. Propranolol is first-line treatment, but response monitoring relies on subjective clinical assessment. Semi-automated photographic erythema quantification may offer a reproducible, low-cost adjunct monitoring tool. Objectives To develop a semi-automated Python-based erythema quantification tool for serial clinical photographs of IH, evaluate its feasibility and intra-rater reliability, and characterise the relationship between colour-based erythema change and clinician-assessed composite response. Methods Retrospective analysis of a prospective photographic registry at a tertiary paediatric surgery centre. Forty-nine infants with IH treated with propranolol were included. Serial clinical photographs (n = 251) were analysed using a custom Python tool. The erythema index (EI = [R − G] / [R + G + B]), a formula validated for quantification of cutaneous erythema from digital photographs, was calculated from manually selected lesion regions of interest (ROI). Intra-rater reliability was assessed by re-rating 22 photographs from five patients one week apart. Absolute EI change was correlated with prospectively recorded, blinded clinician response scores (0–10). Results Of 251 photographs, 242 (96.4%) were analysable (mean 4.9 visits per patient, range 2–11). Intra-rater reliability was high: ICC(A,1) = 0.990(95% CI 0.97–1.00); Bland–Altman mean difference − 0.005 EI units (95% limits of agreement − 0.023 to + 0.013). Mean baseline EI was 0.122 ± 0.058 and mean final EI was 0.115 ± 0.053. Absolute EI change did not correlate with clinician response scores (Pearson r = − 0.084, 95% CI − 0.357 to 0.202, p = 0.566; Spearman r = − 0.087, p = 0.554), consistent across three sensitivity analyses. Conclusions Semi-automated erythema quantification from clinical photographs of IH is feasible with high intra-rater reliability. These pilot findings should be interpreted as hypothesis-generating; the study is underpowered for definitive correlation testing, and prospective replication in an adequately powered cohort is required. In this pilot cohort, colour-based EI change alone was insufficient to track the clinician’s composite response assessment under real-world uncalibrated photography conditions, consistent with the partial-biomarker nature of colour-only analysis. Prospective studies with standardised photography incorporating colorimetric calibration and composite colour-plus-area scoring are warranted.
- Open Access
- 13 September 2026
- Published by MDPI AG in Epigenomes
- Vol. 10 (3) , 58
Genome-Wide DNA Methylation Profiling Reveals Stage- and Severity-Associated Epigenetic Alterations in Children with Posterior Urethral Valve-Associated Chronic Kidney Disease
Background: Chronic kidney disease (CKD) is an important cause of morbidity in children, particularly in those with congenital anomalies of the kidney and urinary tract. Although epigenetic alterations have been implicated in CKD, stage-associated genome-wide DNA methylation changes remain poorly characterized in posterior urethral valves (PUV). This study aimed to characterize DNA methylation patterns across CKD stages in children with PUV and identify potential methylation markers associated with CKD severity. Methods: Genome-wide DNA methylation profiling was performed on peripheral blood DNA from 20 boys with PUV stratified by CKD stage and 19 age-matched healthy male controls using the Illumina MethylationEPIC v2.0 array. Analyses included a global stage-wise model, stage-specific comparisons against controls and between CKD stages, an overall PUV-associated CKD-versus-control model, functional enrichment analysis, candidate CKD progression gene analysis, and CKD severity-associated methylation analysis. Results: A global stage-wise analysis identified 11,134 CpG sites showing significant methylation variation across controls and PUV-associated CKD. Differential methylation burden was limited in early CKD stages but increased markedly in advanced CKD, with 4734 and 20,242 DMPs identified in Stage 4 and Stage 5, respectively. DMP-associated genes in advanced CKD stages showed enrichment of immune-related, structural remodeling, and intracellular signaling pathways. Candidate gene analysis identified significant methylation changes in previously reported CKD progression-associated genes, with greater representation in advanced CKD stages. CKD severity-associated analysis identified cg16879596_BC21, annotated to CYP3A5, as positively associated with CKD severity (r = 0.74, FDR = 1.32 × 10−5). Methylation at this CpG site increased across CKD stages and showed strong internal discrimination between PUV-associated CKD patients and controls (AUC = 0.947, 95% CI = 0.887–1.000). Conclusions: PUV-associated CKD is characterized by stage-associated DNA methylation changes, with a marked increase in methylation burden in advanced CKD stages. The findings highlight immune, structural remodeling, and signaling pathways associated with advanced CKD and identify CYP3A5 methylation as a potential marker of CKD severity. In future, larger longitudinal studies with independent validation and functional integration are required.
- 13 September 2026
- Published by MDPI AG in Epigenomes
- Vol. 10 (3) , 58
Open AccessGenome-Wide DNA Methylation Profiling Reveals Stage- and Severity-Associated Epigenetic Alterations in Children with Posterior Urethral Valve-Associated Chronic Kidney Disease
Background: Chronic kidney disease (CKD) is an important cause of morbidity in children, particularly in those with congenital anomalies of the kidney and urinary tract. Although epigenetic alterations have been implicated in CKD, stage-associated genome-wide DNA methylation changes remain poorly characterized in posterior urethral valves (PUV). This study aimed to characterize DNA methylation patterns across CKD stages in children with PUV and identify potential methylation markers associated with CKD severity. Methods: Genome-wide DNA methylation profiling was performed on peripheral blood DNA from 20 boys with PUV stratified by CKD stage and 19 age-matched healthy male controls using the Illumina MethylationEPIC v2.0 array. Analyses included a global stage-wise model, stage-specific comparisons against controls and between CKD stages, an overall PUV-associated CKD-versus-control model, functional enrichment analysis, candidate CKD progression gene analysis, and CKD severity-associated methylation analysis. Results: A global stage-wise analysis identified 11,134 CpG sites showing significant methylation variation across controls and PUV-associated CKD. Differential methylation burden was limited in early CKD stages but increased markedly in advanced CKD, with 4734 and 20,242 DMPs identified in Stage 4 and Stage 5, respectively. DMP-associated genes in advanced CKD stages showed enrichment of immune-related, structural remodeling, and intracellular signaling pathways. Candidate gene analysis identified significant methylation changes in previously reported CKD progression-associated genes, with greater representation in advanced CKD stages. CKD severity-associated analysis identified cg16879596_BC21, annotated to CYP3A5, as positively associated with CKD severity (r = 0.74, FDR = 1.32 × 10−5). Methylation at this CpG site increased across CKD stages and showed strong internal discrimination between PUV-associated CKD patients and controls (AUC = 0.947, 95% CI = 0.887–1.000). Conclusions: PUV-associated CKD is characterized by stage-associated DNA methylation changes, with a marked increase in methylation burden in advanced CKD stages. The findings highlight immune, structural remodeling, and signaling pathways associated with advanced CKD and identify CYP3A5 methylation as a potential marker of CKD severity. In future, larger longitudinal studies with independent validation and functional integration are required.
- 3 June 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (5) , 106058
Stretched penile length in boys with hypospadias: Population-based analysis using validated nomogram
- 3 June 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (5) , 106058
Stretched penile length in boys with hypospadias: Population-based analysis using validated nomogram
- 21 February 2026
- Published by Springer Nature in Endocrine Pathology
- Vol. 37 (1) , 12
Validation of the Reticulin Algorithm for Adrenocortical Neoplasms: Assessing Diagnostic Accuracy Across All Age Groups and Histological Subtypes
- 21 February 2026
- Published by Springer Nature in Endocrine Pathology
- Vol. 37 (1) , 12
Validation of the Reticulin Algorithm for Adrenocortical Neoplasms: Assessing Diagnostic Accuracy Across All Age Groups and Histological Subtypes
- Open Access
- 1 October 2025
- Published by Wolters Kluwer Health in Indian Journal of Cancer
- Vol. 62 (4) , 521-527
Role of miRNA in diagnosis of Wilms tumor and neuroblastoma
Background: Wilms tumor (WT) and Neuroblastoma (Nb) are the two most common pediatric abdominal tumors that are difficult to differentiate due to anatomical proximity and often need an invasive procedure such as fine needle aspiration or biopsy. Pediatric tumors have differential expression of miRNA that can be used as a non invasive method to differentiate. Based upon the existing published literature, we designed a panel of four miRNAs ( miR1180 , miR143 , miR124 , and miR34a ) to differentiate WT from Nb. Methods: This was a prospective study conducted over 2 years (2019–2021) at our center. A total of 17 cases, including 10 cases of WT and seven cases of Nb, were included in this study. Ribonucleic acid (RNA) extraction was conducted after confirmation of diagnosis, which was reverse transcribed to complementary deoxyribonucleic acid (cDNA). Real time polymerase chain reaction using cDNA was performed for analyzing expression levels of miR1180 , 143 , 124 , and 34a . Results: The two biomarkers differentially expressed between these patients are miR143 and miR124 3p . miR143 is down regulated in WT (80% of cases), while up regulated in Nb (71.4% of cases), while miR124 3p is up regulated in WT (6/10:60%) and down-regulated in Nb cases. Conclusions: We conclude that miR143 and 124 might prove as useful biomarkers to differentiate between WT and Nb; however, more comprehensive evaluation is required for confirmation of the same.
- 1 October 2025
- Published by Wolters Kluwer Health in Indian Journal of Cancer
- Vol. 62 (4) , 521-527
Open AccessRole of miRNA in diagnosis of Wilms tumor and neuroblastoma
Background: Wilms tumor (WT) and Neuroblastoma (Nb) are the two most common pediatric abdominal tumors that are difficult to differentiate due to anatomical proximity and often need an invasive procedure such as fine needle aspiration or biopsy. Pediatric tumors have differential expression of miRNA that can be used as a non invasive method to differentiate. Based upon the existing published literature, we designed a panel of four miRNAs ( miR1180 , miR143 , miR124 , and miR34a ) to differentiate WT from Nb. Methods: This was a prospective study conducted over 2 years (2019–2021) at our center. A total of 17 cases, including 10 cases of WT and seven cases of Nb, were included in this study. Ribonucleic acid (RNA) extraction was conducted after confirmation of diagnosis, which was reverse transcribed to complementary deoxyribonucleic acid (cDNA). Real time polymerase chain reaction using cDNA was performed for analyzing expression levels of miR1180 , 143 , 124 , and 34a . Results: The two biomarkers differentially expressed between these patients are miR143 and miR124 3p . miR143 is down regulated in WT (80% of cases), while up regulated in Nb (71.4% of cases), while miR124 3p is up regulated in WT (6/10:60%) and down-regulated in Nb cases. Conclusions: We conclude that miR143 and 124 might prove as useful biomarkers to differentiate between WT and Nb; however, more comprehensive evaluation is required for confirmation of the same.
- 24 August 2025
- Published by Springer Nature in Pediatric Surgery International
- Vol. 41 (1) , 1-8
Serum matrix metalloproteinase-7 (MMP-7) as a Biomarker for differentiating biliary atresia from neonatal hepatitis: evidence synthesis through systematic review and meta-analysis
Purpose Biliary atresia (BA) requires timely differentiation from neonatal hepatitis (NH) and early surgery for optimal outcomes. This systematic review and meta-analysis evaluated the diagnostic performance of serum Matrix metalloproteinase-7 (MMP-7) as a biomarker for differentiating BA from NH. Methods The PRISMA-DTA compliant synthesis was based upon primary data available till date, assessing the role of MMP-7 in diagnosing BA. Studies reporting diagnostic accuracy metrics were included. Pooled sensitivity, specificity, likelihood ratios, diagnostic odds ratio (DOR) and area under the summary receiver operating characteristic (SROC) curve were calculated. Results Twenty-four studies (7298 participants: 3301 BA, 2,930 NH and 1067 controls) were analysed. The serum MMP-7 values ranged from 1.2 to 10.3 ng/mL in controls, 1.88–12.57 ng/mL in NH and 10.26–121.1 ng/mL in BA, with interquartile ranges spanning 1.08–25.3, 0.78–34.0 and 3.38–368.0 ng/mL, respectively. Median serum MMP-7 levels were consistently higher in BA vis-a-vis NH and the control population. Pooled sensitivity and specificity of MMP-7 as a diagnostic biomarker were 0.94 and 0.88, respectively. The DOR was 120.09 and the SROC AUC was 0.967. Conclusion Serum MMP-7 demonstrates excellent diagnostic accuracy for differentiating BA from NH. Further research should focus on assay standardization and age-specific reference ranges to optimize clinical utility.
- 24 August 2025
- Published by Springer Nature in Pediatric Surgery International
- Vol. 41 (1) , 1-8
Serum matrix metalloproteinase-7 (MMP-7) as a Biomarker for differentiating biliary atresia from neonatal hepatitis: evidence synthesis through systematic review and meta-analysis
Purpose Biliary atresia (BA) requires timely differentiation from neonatal hepatitis (NH) and early surgery for optimal outcomes. This systematic review and meta-analysis evaluated the diagnostic performance of serum Matrix metalloproteinase-7 (MMP-7) as a biomarker for differentiating BA from NH. Methods The PRISMA-DTA compliant synthesis was based upon primary data available till date, assessing the role of MMP-7 in diagnosing BA. Studies reporting diagnostic accuracy metrics were included. Pooled sensitivity, specificity, likelihood ratios, diagnostic odds ratio (DOR) and area under the summary receiver operating characteristic (SROC) curve were calculated. Results Twenty-four studies (7298 participants: 3301 BA, 2,930 NH and 1067 controls) were analysed. The serum MMP-7 values ranged from 1.2 to 10.3 ng/mL in controls, 1.88–12.57 ng/mL in NH and 10.26–121.1 ng/mL in BA, with interquartile ranges spanning 1.08–25.3, 0.78–34.0 and 3.38–368.0 ng/mL, respectively. Median serum MMP-7 levels were consistently higher in BA vis-a-vis NH and the control population. Pooled sensitivity and specificity of MMP-7 as a diagnostic biomarker were 0.94 and 0.88, respectively. The DOR was 120.09 and the SROC AUC was 0.967. Conclusion Serum MMP-7 demonstrates excellent diagnostic accuracy for differentiating BA from NH. Further research should focus on assay standardization and age-specific reference ranges to optimize clinical utility.
- Open Access
- 21 May 2025
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 51 (1) , 1-6
Comparison of Microvessel Density and Growth Factor Levels Between Inner and Outer Prepuce in Distal Hypospadias*
Objective: Preputial flaps are frequently used in hypospadias repair, but the heal ing potential of preputial tissue remains a concern. This study aimed to evaluate the microvessel density (MVD) and growth factor receptor levels (VEGFR and TGF-!R) in the prepuce of patients with hypospadias compared to controls and to compare these parameters between the inner and outer preputial layers to determine their relative suitability for hypospadias repair. Methods: The study included children under 14 years of age undergoing primary distal hypospadias surgery as cases and individuals undergoing elective circumcision as controls. Specimens from the inner and outer prepuce were collected, and immunohisto chemical staining was performed using CD31 antibodies to assess MVD and VEGFR and TGF-!R antibodies to evaluate growth factor levels. The staining intensity was semi quantitatively analyzed using a histological scoring system. Results: Microvessel density was significantly higher in the inner prepuce than the outer prepuce in both cases and controls (P < .05), suggesting a potential advantage of inner prepuce tissue in hypospadias repair. Conversely, VEGFR levels were significantly higher in the outer prepuce in cases (P < .05), indicating different healing potentials between these layers. Transforming growth factor ! receptor levels were significantly lower in both the inner and outer prepuce of controls compared to cases (P < .05). Other findings did not reach statistical significance. Conclusion: The higher MVD in the inner prepuce suggests it may be preferable for hypospadias repair. However, the differential VEGFR levels between the inner and outer prepuce highlight complex healing dynamics, emphasizing the need for further research to draw definitive conclusions. Cite this article as: Prasad G, Himanshu, Dhua AK, et!al. Comparison of microvessel density and growth factor levels between inner and outer prepuce in distal hypospadias. Urol Res Pract. 2025;51(1):1-6.
- 21 May 2025
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 51 (1) , 1-6
Open AccessComparison of Microvessel Density and Growth Factor Levels Between Inner and Outer Prepuce in Distal Hypospadias*
Objective: Preputial flaps are frequently used in hypospadias repair, but the heal ing potential of preputial tissue remains a concern. This study aimed to evaluate the microvessel density (MVD) and growth factor receptor levels (VEGFR and TGF-!R) in the prepuce of patients with hypospadias compared to controls and to compare these parameters between the inner and outer preputial layers to determine their relative suitability for hypospadias repair. Methods: The study included children under 14 years of age undergoing primary distal hypospadias surgery as cases and individuals undergoing elective circumcision as controls. Specimens from the inner and outer prepuce were collected, and immunohisto chemical staining was performed using CD31 antibodies to assess MVD and VEGFR and TGF-!R antibodies to evaluate growth factor levels. The staining intensity was semi quantitatively analyzed using a histological scoring system. Results: Microvessel density was significantly higher in the inner prepuce than the outer prepuce in both cases and controls (P < .05), suggesting a potential advantage of inner prepuce tissue in hypospadias repair. Conversely, VEGFR levels were significantly higher in the outer prepuce in cases (P < .05), indicating different healing potentials between these layers. Transforming growth factor ! receptor levels were significantly lower in both the inner and outer prepuce of controls compared to cases (P < .05). Other findings did not reach statistical significance. Conclusion: The higher MVD in the inner prepuce suggests it may be preferable for hypospadias repair. However, the differential VEGFR levels between the inner and outer prepuce highlight complex healing dynamics, emphasizing the need for further research to draw definitive conclusions. Cite this article as: Prasad G, Himanshu, Dhua AK, et!al. Comparison of microvessel density and growth factor levels between inner and outer prepuce in distal hypospadias. Urol Res Pract. 2025;51(1):1-6.